Press Releases from DelveInsight Business Research LLP (2391 total)
Infliximab Biosimilar Insight 2023, by DelveInsight | Major players: Celltrion, …
DelveInsight's "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
Eosinophilic Asthma Market to Show a Rise During the Forecast Period | Major com …
DelveInsight's "Eosinophilic Asthma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Eosinophilic Asthma, historical and forecasted epidemiology as well as the Eosinophilic Asthma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Eosinophilic Asthma market report provides current treatment practices, emerging drugs, Eosinophilic Asthma market share of the individual therapies, and current and forecasted Eosinophilic Asthma market…
Cushing's Syndrome Market to Show a Rise During the Forecast Period | Major play …
DelveInsight's "Cushing's Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cushing's Syndrome, historical and forecasted epidemiology as well as the Cushing's Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Cushing's Syndrome market report provides current treatment practices, emerging drugs, Cushing's Syndrome market share of the individual therapies, and current and forecasted Cushing's Syndrome market…
Functional Dyspepsia Market to Show a Rise During the Forecast Period | Major co …
DelveInsight's "Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as the Functional Dyspepsia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Functional Dyspepsia market report provides current treatment practices, emerging drugs, Functional Dyspepsia market share of the individual therapies, and current and forecasted Functional Dyspepsia market…
Ependymoma Market to Show a Rise During the Forecast Period | Companies: Fera Ph …
DelveInsight's "Ependymoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Ependymoma, historical and forecasted epidemiology as well as the Ependymoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Ependymoma market report provides current treatment practices, emerging drugs, Ependymoma market share of the individual therapies, and current and forecasted Ependymoma market size from 2019 to 2032 segmented…
Typhoid Fever Market to Show a Rise During the Forecast Period | Major players: …
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Typhoid Fever market report provides current treatment practices, emerging drugs, Typhoid Fever market share of the individual therapies, and current and forecasted Typhoid Fever market…
Hyperlipidemia Market to Show a Rise During the Forecast Period | Major players: …
DelveInsight's "Hyperlipidemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hyperlipidemia, historical and forecasted epidemiology as well as the Hyperlipidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Hyperlipidemia market report provides current treatment practices, emerging drugs, Hyperlipidemia market share of the individual therapies, and current and forecasted Hyperlipidemia market size from 2019 to 2032 segmented…
Mammography Devices Market Insight & Forecast by DelveInsight
Global Mammography Devices Market was valued at USD 1.78 billion in 2020, growing at a CAGR of 9.15% during the forecast period from 2023 to 2028, to reach USD 3.65 billion by 2028. The demand for Mammography Devices is primarily witnessing growth on account of the increasing prevalence of breast cancer, technological advancements in breast imaging, and increasing focus on creating awareness regarding routine breast cancer screening programs.
DelveInsight's "Mammography Devices…
Adenoid Cystic Carcinomas Pipeline Analysis Covering Clinical Trials, Emerging T …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Adenoid Cystic Carcinomas therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Adenoid Cystic Carcinomas Pipeline Insight"…
Epidermal Growth Factor Receptor (EGFR) Antagonists Pipeline Analysis Covering C …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Epidermal Growth Factor Receptor Antagonists therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Epidermal Growth Factor…
Head and Neck Cancer (HNC) Pipeline Analysis Covering Clinical Trials, Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 120+ pipeline drugs in the Head and Neck Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Head and Neck Cancer…
Neuroblastoma Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FD …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 35+ key pharma and biotech companies are working on 35+ pipeline drugs in the Neuroblastoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Neuroblastoma Pipeline Insight" report by DelveInsight provides…
Minimal Residual Disease Pipeline Analysis Covering Clinical Trials, Emerging Th …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 8+ pipeline drugs in the Minimal Residual Disease therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Minimal Residual Disease Pipeline Insight"…
Primary Progressive Multiple Sclerosis Pipeline Analysis Covering Clinical Trial …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Primary Progressive Multiple Sclerosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Primary Progressive Multiple Sclerosis…
Renal Cell Carcinoma Pipeline, FDA Approvals, Clinical Trials Developments, Comp …
DelveInsight's, "Renal Cell Carcinoma Pipeline Insight" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Renal Cell Carcinoma pipeline landscape. It covers the Renal Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cell Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Psoriasis Pipeline, FDA Approvals, Clinical Trials Development, and Companies | …
DelveInsight's, "Psoriasis Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Psoriasis pipeline landscape. It covers the Psoriasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Psoriasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Psoriasis Pipeline Report
• DelveInsight's Psoriasis pipeline…
Refractory Multiple Myeloma Pipeline, FDA Approvals, Clinical Trials Development …
DelveInsight's, "Refractory Multiple Myeloma Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Refractory Multiple Myeloma pipeline landscape. It covers the Refractory Multiple Myeloma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Refractory Multiple Myeloma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Chemotherapy-induced Hearing Loss Market to Show a Rise During the Forecast Peri …
DelveInsight's "Chemotherapy-induced Hearing Loss Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chemotherapy-induced Hearing Loss, historical and forecasted epidemiology as well as the Chemotherapy-induced Hearing Loss market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chemotherapy-induced Hearing Loss market report provides current treatment practices, emerging drugs, Chemotherapy-induced Hearing Loss market share of the individual therapies, and current…
Burn Pain Market to Show a Rise During the Forecast Period | Major players: Medi …
DelveInsight's "Burn Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology as well as the Burn Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Burn Pain market report provides current treatment practices, emerging drugs, Burn Pain market share of the individual therapies, and current and forecasted Burn Pain market…
CAR-T Therapy Pipeline, FDA Approvals, Clinical Trials Development, Companies | …
DelveInsight's, "CAR-T Therapy Pipeline Insight" report provides comprehensive insights about 200+ companies and 252+ pipeline drugs in the CAR-T Therapy pipeline landscape. It covers the CAR-T Therapy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CAR-T Therapy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the CAR-T…
Orthopedic Prosthesis Devices Market to Showcase Robust Growth in the Upcoming Y …
Global orthopedic prosthesis devices market was valued at USD 2.22 billion in 2021, growing at a CAGR of 5.84% during the forecast period from 2023 to 2028 to reach USD 3.10 billion by 2028.
Factors such as the growing prevalence of lifestyle disorders such as diabetes, rising number of trauma cases, the increasing number of sports-related injuries, and technological advancements in product development among other factors are expected to drive…
Powered Surgical Instruments Market to Showcase Robust Growth in the Upcoming Ye …
Global Powered Surgical Instruments Market was valued at USD 2.06 billion in 2021, growing at a CAGR of 4.26% during the forecast period from 2023 to 2028 to reach USD 2.65 billion by 2028. Factors such as rising aging population resulting in the increasing prevalence of degenerative bone disorders and ophthalmic conditions, rising number of brain cancers, increasing number of trauma cases, and growth in the product innovation are stimulating…
Glioblastoma Pipeline, FDA Approvals, Clinical Trials Developments, Companies | …
DelveInsight's, "Glioblastoma Pipeline Insight" report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in the Glioblastoma pipeline landscape. It covers the Glioblastoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioblastoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioblastoma Pipeline Report
• DelveInsight's Glioblastoma pipeline…
Chronic Spontaneous Urticaria Market to Show a Rise During the Forecast Period | …
DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as well as the Chronic Spontaneous Urticaria market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chronic Spontaneous Urticaria market report provides current treatment practices, emerging drugs, Chronic Spontaneous Urticaria market share of the individual therapies, and current…
Gender Dysphoria Market to Show a Rise During the Forecast Period | Major compan …
DelveInsight's "Gender Dysphoria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gender Dysphoria, historical and forecasted epidemiology as well as the Gender Dysphoria market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Gender Dysphoria market report provides current treatment practices, emerging drugs, Gender Dysphoria market share of the individual therapies, and current and forecasted Gender Dysphoria market…
Osteoarthritis Pipeline, FDA Approvals, Clinical Trials Developments, and Compan …
DelveInsight's, "Osteoarthritis Pipeline Insight" report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in the Osteoarthritis pipeline landscape. It covers the Osteoarthritis pipeline drug profiles, including Osteoarthritis clinical and nonclinical stage products. It also covers the Osteoarthritis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Osteoarthritis Pipeline Report
• DelveInsight's Osteoarthritis…
Germany Healthcare Outlook Report 2023 | Major companies: Fresenius AG, Bayer AG …
DelveInsight's "Germany Healthcare Outlook Report, 2023," report provides comprehensive insights into the healthcare scenario, regulatory policies, and reimbursement landscape in Germany. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market in Germany.
According to DelveInsight's analysis,…
Idiopathic Pulmonary Fibrosis Pipeline, FDA Approvals, Clinical Trials Developme …
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Major Depressive Disorder Pipeline, FDA Approvals, Clinical Trials Developments …
DelveInsight's, "Major Depressive Disorder Pipeline Insight" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Major Depressive Disorder pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Multiple Sclerosis Pipeline, FDA Approvals, Clinical Trials Development and Comp …
DelveInsight's, "Multiple Sclerosis Pipeline Insight" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Sclerosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Multiple…
Myelodysplastic Syndrome Pipeline, FDA Approvals, Clinical Trials Development an …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the Myelodysplastic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelodysplastic Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myelodysplastic Syndrome…
Schizophrenia Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FD …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 70+ key pharma and biotech companies are working on 70+ pipeline drugs in the Schizophrenia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Schizophrenia Pipeline Insight" report by DelveInsight provides…
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Analysis Covering Clinic …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 42+ pipeline drugs in the EGFR Non-Small Cell Lung Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"EGFR Non-Small Cell…
Wet Age-Related Macular Degeneration (Wet AMD) Pipeline Analysis Covering Clinic …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 75+ key pharma and biotech companies are working on 80+ pipeline drugs in the Wet Age-Related Macular Degeneration (Wet AMD) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Wet Age-Related…
Acute Myeloid Leukaemia Pipeline Analysis Covering Clinical Trials, Emerging The …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 150+ key pharma and biotech companies are working on 150+ pipeline drugs in the Acute Myeloid Leukaemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Acute Myeloid Leukaemia Pipeline Insight"…
Peanut Allergy Pipeline Analysis Covering Clinical Trials, Emerging Therapies, F …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Peanut Allergy therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Peanut Allergy Pipeline Insight" report by…
Chronic Liver Disease Market to Show a Rise During the Forecast Period | Major c …
DelveInsight's "Chronic Liver Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Liver Disease, historical and forecasted epidemiology as well as the Chronic Liver Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chronic Liver Disease market report provides current treatment practices, emerging drugs, Chronic Liver Disease market share of the individual therapies, and current…
Clear Cell Carcinoma Market to Show a Rise During the Forecast Period | Major co …
DelveInsight's "Clear Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Clear Cell Carcinoma, historical and forecasted epidemiology as well as the Clear Cell Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Clear Cell Carcinoma market report provides current treatment practices, emerging drugs, Clear Cell Carcinoma market share of the individual therapies, and current…
Chronic Hemodialysis Market to Show a Rise During the Forecast Period | Major co …
DelveInsight's "Chronic Hemodialysis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Hemodialysis, historical and forecasted epidemiology as well as the Chronic Hemodialysis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chronic Hemodialysis market report provides current treatment practices, emerging drugs, Chronic Hemodialysis market share of the individual therapies, and current and forecasted Chronic Hemodialysis market…
Chronic Brain Damage Market to Show a Rise During the Forecast Period | Major co …
DelveInsight's "Chronic Brain Damage Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Brain Damage, historical and forecasted epidemiology as well as the Chronic Brain Damage market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chronic Brain Damage market report provides current treatment practices, emerging drugs, Chronic Brain Damage market share of the individual therapies, and current…
Chiari Malformation Market to Show a Rise During the Forecast Period | Major com …
DelveInsight's "Chiari Malformation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chiari Malformation, historical and forecasted epidemiology as well as the Chiari Malformation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chiari Malformation market report provides current treatment practices, emerging drugs, Chiari Malformation market share of the individual therapies, and current and forecasted Chiari Malformation market…
Trauma Fixation Devices Market to Showcase Robust Growth in the Upcoming Years | …
The global trauma fixation devices market was valued at USD 7.03 billion in 2022, growing at a CAGR of 6.42% during the forecast period from 2023 to 2028 to reach USD 10.21 billion by 2028. Factors such as the rising demand for technologically advanced products, increasing geriatric population, rising number of accident and trauma cases, growing prevalence of degenerative bone disorders, and the rising number of sports-related injuries are expected…
Positive Air Pressure Device Market: Insights into Competitive Landscape and Mar …
DelveInsight's 'Positive Air Pressure Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Positive Air Pressure Devices and the historical and forecasted Positive Air Pressure Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Request for a sample copy of the Positive Air Pressure Device Market report @ https://www.delveinsight.com/sample-request/positive-air-pressure-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
The Positive Air Pressure Device market report offers an overview of the Positive…
Acute Ischemic Stroke Pipeline Analysis Covering Clinical Trials, Emerging Thera …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 35+ key pharma and biotech companies are working on 35+ pipeline drugs in the Acute Ischemic Stroke therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Acute Ischemic Stroke Pipeline Insight"…
Pyoderma Gangrenosum Market to Show Incremental Growth During the Forecast Perio …
DelveInsight's "Pyoderma Gangrenosum Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pyoderma Gangrenosum, historical and forecasted epidemiology as well as the Pyoderma Gangrenosum market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Pyoderma Gangrenosum market report provides current treatment practices, emerging drugs, Pyoderma Gangrenosum market share of the individual therapies, and current and forecasted Pyoderma Gangrenosum market…
CNS Lymphoma Market to Show a Rise During the Forecast Period | Major players: S …
DelveInsight's "CNS Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CNS Lymphoma, historical and forecasted epidemiology as well as the CNS Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The CNS Lymphoma market report provides current treatment practices, emerging drugs, CNS Lymphoma market share of the individual therapies, and current and forecasted CNS Lymphoma market…
Beta-thalassemia (B-thal) Pipeline Analysis Covering Clinical Trials, Emerging T …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 22+ key pharma and biotech companies are working on 22+ pipeline drugs in the Beta Thalassemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Beta-thalassemia (B-thal) Pipeline Insight" report by…
Community-Acquired Bacterial Pneumonia Market to Show a Rise During the Forecast …
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
DDR Defective Tumors Market to Show a Rise During the Forecast Period, asserts D …
DelveInsight's "DDR Defective Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DDR Defective Tumors, historical and forecasted epidemiology as well as the DDR Defective Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The DDR Defective Tumors market report provides current treatment practices, emerging drugs, DDR Defective Tumors market share of the individual therapies, and current…
Invasive Pneumococcal Disease Market to Show a Rise During the Forecast Period | …
DelveInsight's "Invasive Pneumococcal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Invasive Pneumococcal Disease, historical and forecasted epidemiology as well as the Invasive Pneumococcal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Invasive Pneumococcal Disease market report provides current treatment practices, emerging drugs, Invasive Pneumococcal Disease market share of the individual therapies, and current…
